Raleigh Capital Management’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16
Closed -$2.2K 1077
2024
Q4
$2.2K Hold
16
﹤0.01% 826
2024
Q3
$2.46K Buy
+16
New +$2.42K ﹤0.01% 794
2024
Q2
Sell
-125
Closed -$18.5K 1027
2024
Q1
$18.5K Buy
125
+111
+793% +$15.9K 0.01% 435
2023
Q4
$1.85K Hold
14
﹤0.01% 874
2023
Q3
$1.74K Buy
14
+1
+8% +$133 ﹤0.01% 785
2023
Q2
$1.79K Sell
13
-386
-97% -$50.9K ﹤0.01% 740
2023
Q1
$51.7K Buy
399
+373
+1,435% +$48.7K 0.03% 246
2022
Q4
$3.51K Sell
26
-25
-49% -$3.31K ﹤0.01% 602
2022
Q3
$6K Buy
51
+25
+96% +$3.22K ﹤0.01% 467
2022
Q2
$3K Sell
26
-5
-16% -$655 ﹤0.01% 519
2022
Q1
$4K Sell
31
-8,462
-100% -$1.12M ﹤0.01% 497
2021
Q4
$1.2M Buy
+8,493
New +$1.13M 1.23% 21

Other funds holding XLV

Raleigh Capital Management's XLV Position: Q1 2025 in Review

Raleigh Capital Management sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q1 2025, closing a stake of 16 shares — an estimated $2.2K sold.

Raleigh Capital Management first reported a position in XLV in Q4 2021 and held it in 12 quarters. The position peaked at $1.2M in Q4 2021. 1,767 funds tracked by Wall St. Rank hold XLV as of Q1 2025.

  • Raleigh Capital Management reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q1 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 16 State Street Health Care Select Sector SPDR ETF shares in Q1 2025, an estimated $2.2K.
  • Raleigh Capital Management first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2021 and held it in 12 quarters.
  • Raleigh Capital Management's State Street Health Care Select Sector SPDR ETF position peaked at $1.2M in Q4 2021.
  • 1,767 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2025.

Based on Raleigh Capital Management's 13F filing for Q1 2025, filed 29 Apr 2025.